Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
23 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/23/3087397/0/en/Instil-Bio-and-ImmuneOnco-to-Host-Investor-and-Analyst-Breakfast-to-Discuss-the-Evolving-PD-L-1xVEGF-Bispecific-Antibody-Landscape-and-Clinical-Trial-Updates-During-the-2025-ASCO-A.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3086415/0/en/Instil-Bio-and-ImmuneOnco-Announced-the-Phase-2-Trial-in-First-line-NSCLC-of-IMM2510-AXN-2510-2510-a-PD-L1xVEGF-Bispecific-Antibody-in-Combination-with-Chemotherapy-in-China-is-on-.html
14 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/14/3009179/0/en/Instil-Bio-Announces-Clinical-Progress-in-China-for-IMM2510-SYN-2510-a-Clinical-Stage-PD-L1xVEGF-Bispecific-Antibody.html
13 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/13/2980113/0/en/Instil-Bio-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/16/2946438/0/en/Instil-Bio-and-ImmuneOnco-Announce-Global-Registrational-Strategy-for-PD-L1xVEGF-Bispecific-Antibody-SYN-2510-IMM2510-in-Non-Small-Cell-Lung-Cancer-and-Triple-Negative-Breast-Cance.html
ABOUT THIS PAGE